SCHEMBL2853154

SCHEMBL2853154

O=C(Nc1ccc(F)c(F)c1)Oc1cnn(-c2ccc(Cl)cc2)c1C(F)(F)F

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.44
SMN1; SMN2 Q16637 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
MET P08581 4/20 0.42
KCNJ6 P48051 2/20 0.41
KCNJ5 P48544 2/20 0.41
KCNJ3 P48549 2/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
LMNA P02545 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
TSHR P16473 1/20 0.41
CYP2C19 P33261 1/20 0.41
HTR2A P28223 1/20 0.41
HTR2C P28335 1/20 0.41
ORAI1 Q96D31 2/20 0.40
MST1R Q04912 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2852244 0.91 MAPT (0.48) MAPTSMN1; SMN2NPSR1METMEN1
SCHEMBL2854572 0.88 RAB9A (0.44) MAPTSMN1; SMN2NPSR1MEN1KMT2A
SCHEMBL2850258 0.88 MAPT (0.51) MAPTSMN1; SMN2NPSR1MEN1KMT2A
SCHEMBL2853065 0.87 NR3C1 (0.46) MAPTSMN1; SMN2NPSR1MEN1KMT2A
SCHEMBL2860975 0.86 MAPT (0.49) MAPTSMN1; SMN2NPSR1METKCNJ6
SCHEMBL2848317 0.86 MAPT (0.46) MAPTSMN1; SMN2NPSR1METMEN1
SCHEMBL2854221 0.86 MAPT (0.51) MAPTNPSR1MEN1KMT2ALMNA
SCHEMBL2859873 0.86 KCNQ3 (0.46) MAPTSMN1; SMN2NPSR1METORAI1
SCHEMBL2852565 0.86 MAPT (0.42) MAPTSMN1; SMN2NPSR1MEN1KMT2A
SCHEMBL2850524 0.85 MAPT (0.43) MAPTSMN1; SMN2NPSR1METMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1451160-B1 PYRAZOLE-AMIDES FOR USE IN THE TREATMENT OF PAIN ICAGEN INC (US) 2010-01-13 EP claimed